Platelet preservation in cardiac surgery using minimally invasive extracorporeal circulation versus optimized

Brian Beairsto1, Cyril Serrick1, Amanda Fernandez1

  • 1Department of Perfusion, Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.

Perfusion
|September 29, 2022
PubMed
Abstract

Insights

Minimally invasive extracorporeal circulation (MiECC) better preserves platelet function compared to optimized conventional extracorporeal circulation (OpECC). This study found MiECC maintained higher functional platelet counts during cardiopulmonary bypass without increasing blood product use.

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Hematology

Background:

  • Cardiopulmonary bypass (CPB) can cause significant physiological disturbances.
  • Minimally invasive extracorporeal circulation (MiECC) is a strategy to mitigate these effects.
  • Optimized conventional extracorporeal circulation (OpECC) serves as a benchmark for comparison.

Purpose of the Study:

  • To compare the coagulation profile of MiECC versus OpECC.
  • To evaluate differences in platelet function and blood product usage between MiECC and OpECC.
  • To assess the impact of MiECC on key clinical outcomes.

Main Methods:

  • Retrospective analysis of coronary artery bypass grafting (CABG) operations.
  • Inclusion of 112 patients: 61 in the MiECC group and 51 in the OpECC group.
  • Comparison of coagulation profiles, platelet function assays, and blood product transfusion data.

Main Results:

  • No significant differences in red blood cell, plasma, or platelet transfusions between groups.
  • MiECC group showed higher functional platelet counts (136 vs 109 x10^9/L, p=0.027) during CPB.
  • MiECC group demonstrated a higher percentage of functional platelets (86% vs 76%, p=0.003).
  • No significant differences in operative mortality, stroke incidence, or ICU length of stay.

Conclusions:

  • MiECC offers a statistically significant advantage in preserving functional platelets compared to OpECC.
  • Despite no difference in blood transfusions, MiECC demonstrates superior platelet function preservation.
  • MiECC may be a beneficial alternative for mitigating CPB-associated hemostatic disturbances.

Related Concept Videos